Inotuzumab ozogamicin and Novoeight recombinant
Determining the interaction of Inotuzumab ozogamicin and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin-Novolin 70/30
- Inotuzumab ozogamicin-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Inotuzumab ozogamicin-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Inotuzumab ozogamicin-Novolin N
- Inotuzumab ozogamicin-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Inotuzumab ozogamicin-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Inotuzumab ozogamicin Intravenous
- Novoeight recombinant-Inova
- Novoeight recombinant-Inova 4/1 topical
- Novoeight recombinant-Inova 8/2 topical
- Novoeight recombinant-Inova ACT
- Novoeight recombinant-Inrebic